76-90 of 334
Updates in AML Care: Evolving ASH Guidelines for Older Adults
On the Frontlines of AML/ALLUpdates in AML Care: Evolving ASH Guidelines for Older Adults
Shelina Ramnarine, PhD
Mikkael A. Sekeres, MD, MS
Venetoclax and Palbociclib in AML: Exploring New Findings
On the Frontlines of AML/ALLVenetoclax and Palbociclib in AML: Exploring New Findings
Ryan Quigley
Jeffrey Tyner, PhD
Melissa Stewart, PhD
Assessing Quality of Life in Autoimmune Liver Diseases
GI InsightsAssessing Quality of Life in Autoimmune Liver Diseases
Charles Turck, PharmD, BCPS, BCCCP
Alan Bonder, MD
A New Era in Primary Biliary Cholangitis Treatment
GI InsightsA New Era in Primary Biliary Cholangitis Treatment
Charles Turck, PharmD, BCPS, BCCCP
Alan Bonder, MD
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiersSpinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
NeuroFrontiersEarly ALS Patients Show Slowed Decline with Pridopidine Treatment
- advertisement
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstractsSwitching to Risdiplam Maintains Motor Gains in SMA Patients
Ryan Quigley
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
NeuroFrontiersCK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Brian P. McDonough, MD, FAAFP
Tara Graff, DO, MS
Surbhi Sidana, MD
Optimizing Care for Older Adults With FLT3-Mutated AML
On the Frontlines of AML/ALLOptimizing Care for Older Adults With FLT3-Mutated AML
Ryan Quigley
Nicholas Short, MD
ATTRibute-CM Findings on Acoramidis and Cumulative CV Events
On the Frontlines of ATTR-CMATTRibute-CM Findings on Acoramidis and Cumulative CV Events
Ryan Quigley
Ahmad Masri, MD, MS
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Jennifer Caudle, DO, FACOFP
Mansi R. Shah, MD
- advertisement
Redefining ATTR Treatment: Key Mechanisms and Emerging Data
Heart MattersRedefining ATTR Treatment: Key Mechanisms and Emerging Data
Ahmad Masri, MD, MS
ATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
On the Frontlines of ATTR-CMATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
Ryan Quigley
Kevin Alexander, MD
Advances in ATTR-CM: Evolving Diagnostics and Therapeutics
Heart MattersAdvances in ATTR-CM: Evolving Diagnostics and Therapeutics
Kevin Alexander
